Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 23 studies | 38% ± 15% | |
astrocyte | 18 studies | 41% ± 19% | |
B cell | 17 studies | 30% ± 16% | |
oligodendrocyte | 14 studies | 38% ± 15% | |
mast cell | 13 studies | 35% ± 16% | |
microglial cell | 13 studies | 50% ± 16% | |
glutamatergic neuron | 12 studies | 51% ± 28% | |
oligodendrocyte precursor cell | 12 studies | 43% ± 20% | |
fibroblast | 12 studies | 33% ± 15% | |
endothelial cell of lymphatic vessel | 11 studies | 43% ± 22% | |
macrophage | 11 studies | 40% ± 15% | |
GABAergic neuron | 9 studies | 48% ± 23% | |
adipocyte | 9 studies | 28% ± 9% | |
T cell | 8 studies | 34% ± 11% | |
naive B cell | 8 studies | 23% ± 6% | |
smooth muscle cell | 8 studies | 26% ± 5% | |
retinal rod cell | 8 studies | 38% ± 15% | |
myeloid cell | 8 studies | 31% ± 14% | |
pericyte | 7 studies | 28% ± 11% | |
dendritic cell | 7 studies | 37% ± 14% | |
neuron | 6 studies | 44% ± 25% | |
retina horizontal cell | 6 studies | 58% ± 25% | |
retinal cone cell | 6 studies | 31% ± 13% | |
retinal bipolar neuron | 5 studies | 34% ± 18% | |
interneuron | 5 studies | 59% ± 23% | |
memory B cell | 5 studies | 24% ± 5% | |
epithelial cell | 5 studies | 47% ± 20% | |
CD4-positive, alpha-beta T cell | 5 studies | 28% ± 9% | |
CD8-positive, alpha-beta T cell | 5 studies | 25% ± 8% | |
cardiac muscle cell | 5 studies | 24% ± 5% | |
ciliated cell | 5 studies | 29% ± 8% | |
Mueller cell | 5 studies | 50% ± 22% | |
monocyte | 5 studies | 47% ± 13% | |
type I pneumocyte | 5 studies | 29% ± 6% | |
type II pneumocyte | 5 studies | 32% ± 6% | |
hepatocyte | 4 studies | 57% ± 27% | |
CD16-negative, CD56-bright natural killer cell, human | 4 studies | 28% ± 11% | |
granule cell | 4 studies | 41% ± 11% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 29% ± 9% | |
mesothelial cell | 4 studies | 32% ± 11% | |
lymphocyte | 4 studies | 44% ± 19% | |
amacrine cell | 4 studies | 37% ± 12% | |
basal cell | 4 studies | 37% ± 29% | |
leukocyte | 4 studies | 43% ± 18% | |
club cell | 4 studies | 26% ± 7% | |
erythrocyte | 4 studies | 53% ± 30% | |
natural killer cell | 4 studies | 34% ± 9% | |
mononuclear phagocyte | 3 studies | 24% ± 4% | |
plasma cell | 3 studies | 36% ± 10% | |
mucosal invariant T cell | 3 studies | 29% ± 10% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 27% ± 7% | |
vein endothelial cell | 3 studies | 41% ± 25% | |
GABAergic amacrine cell | 3 studies | 37% ± 17% | |
ON-bipolar cell | 3 studies | 48% ± 19% | |
glycinergic amacrine cell | 3 studies | 38% ± 12% | |
rod bipolar cell | 3 studies | 58% ± 22% | |
regulatory T cell | 3 studies | 24% ± 4% | |
endothelial cell of vascular tree | 3 studies | 37% ± 19% | |
cholangiocyte | 3 studies | 55% ± 20% | |
mature NK T cell | 3 studies | 30% ± 18% | |
retinal pigment epithelial cell | 3 studies | 57% ± 23% | |
alveolar macrophage | 3 studies | 44% ± 9% | |
capillary endothelial cell | 3 studies | 29% ± 8% | |
respiratory goblet cell | 3 studies | 30% ± 12% | |
muscle cell | 3 studies | 34% ± 18% | |
mucus secreting cell | 3 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1660.48 | 1445 / 1445 | 100% | 14.57 | 183 / 183 |
pancreas | 100% | 2329.74 | 328 / 328 | 100% | 9.48 | 178 / 178 |
prostate | 100% | 1801.90 | 245 / 245 | 100% | 9.38 | 502 / 502 |
lung | 100% | 2765.89 | 578 / 578 | 100% | 10.18 | 1154 / 1155 |
thymus | 100% | 2606.04 | 653 / 653 | 100% | 11.24 | 604 / 605 |
brain | 100% | 1846.08 | 2635 / 2642 | 100% | 11.17 | 705 / 705 |
uterus | 100% | 2036.21 | 170 / 170 | 99% | 7.41 | 454 / 459 |
breast | 100% | 2015.59 | 459 / 459 | 99% | 10.62 | 1105 / 1118 |
liver | 100% | 1984.48 | 226 / 226 | 99% | 7.85 | 401 / 406 |
bladder | 100% | 1976.76 | 21 / 21 | 98% | 6.82 | 496 / 504 |
kidney | 100% | 1639.72 | 89 / 89 | 98% | 10.60 | 886 / 901 |
adrenal gland | 100% | 2970.72 | 258 / 258 | 97% | 9.23 | 223 / 230 |
stomach | 100% | 1663.04 | 359 / 359 | 97% | 8.95 | 277 / 286 |
intestine | 100% | 2037.78 | 966 / 966 | 96% | 7.14 | 505 / 527 |
skin | 100% | 1708.05 | 1807 / 1809 | 92% | 7.91 | 432 / 472 |
ovary | 100% | 3090.79 | 180 / 180 | 90% | 4.09 | 389 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.53 | 29 / 29 |
muscle | 100% | 1994.75 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2511.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.62 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.14 | 1 / 1 |
blood vessel | 100% | 1745.28 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2224.38 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 95% | 1045.38 | 816 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 2435.60 | 862 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 65% | 3.23 | 52 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032483 | Biological process | regulation of Rab protein signal transduction |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005829 | Cellular component | cytosol |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DENND4A |
Protein name | DENND4A protein C-myc promoter-binding protein (DENN domain-containing protein 4A) DENN domain containing 4A |
Synonyms | MYCPBP IRLB |
Description | FUNCTION: Probable guanine nucleotide exchange factor (GEF) which may activate RAB10. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. According to PubMed:8056341, it may bind to ISRE-like element (interferon-stimulated response element) of MYC P2 promoter. . |
Accessions | H3BSA0 A0A7I2RAZ6 H3BTW5 ENST00000431932.6 [Q7Z401-1] ENST00000635620.2 ENST00000443035.8 Q05C90 Q7Z401 A0A0U1RR27 ENST00000564674.5 ENST00000561863.1 |